![Abstracts presented at the 14th European Colorectal Congress (#ECCStGallen), 29.11.2020–2.12.2020, St.Gallen, Switzerland | SpringerLink Abstracts presented at the 14th European Colorectal Congress (#ECCStGallen), 29.11.2020–2.12.2020, St.Gallen, Switzerland | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10151-021-02408-9/MediaObjects/10151_2021_2408_Figa_HTML.png)
Abstracts presented at the 14th European Colorectal Congress (#ECCStGallen), 29.11.2020–2.12.2020, St.Gallen, Switzerland | SpringerLink
![Pd-l1-binding Molecules Comprising Shiga Toxin A Subunit Scaffolds Poma; Eric ; et al. [Molecular Templates, Inc.] Pd-l1-binding Molecules Comprising Shiga Toxin A Subunit Scaffolds Poma; Eric ; et al. [Molecular Templates, Inc.]](https://uspto.report/patent/app/20210079097/US20210079097A1-20210318-D00002.png)
Pd-l1-binding Molecules Comprising Shiga Toxin A Subunit Scaffolds Poma; Eric ; et al. [Molecular Templates, Inc.]
![Ustekinumab binds to the p40 subunit of iL-12 and iL-23, preventing... | Download Scientific Diagram Ustekinumab binds to the p40 subunit of iL-12 and iL-23, preventing... | Download Scientific Diagram](https://www.researchgate.net/profile/Parakkal-Deepak/publication/310309958/figure/fig1/AS:428712375132160@1479224403553/Ustekinumab-binds-to-the-p40-subunit-of-iL-12-and-iL-23-preventing-binding-with-the_Q640.jpg)
Ustekinumab binds to the p40 subunit of iL-12 and iL-23, preventing... | Download Scientific Diagram
![Cancers | Free Full-Text | Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma | HTML Cancers | Free Full-Text | Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma | HTML](https://www.mdpi.com/cancers/cancers-13-04977/article_deploy/html/images/cancers-13-04977-g007.png)
Cancers | Free Full-Text | Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma | HTML
![Transcriptome analysis of five ovarian stages reveals gonad maturation in female Macrobrachium nipponense | BMC Genomics | Full Text Transcriptome analysis of five ovarian stages reveals gonad maturation in female Macrobrachium nipponense | BMC Genomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12864-021-07737-5/MediaObjects/12864_2021_7737_Fig6_HTML.png)
Transcriptome analysis of five ovarian stages reveals gonad maturation in female Macrobrachium nipponense | BMC Genomics | Full Text
![Biomedicines | Free Full-Text | Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis | HTML Biomedicines | Free Full-Text | Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis | HTML](https://www.mdpi.com/biomedicines/biomedicines-09-01484/article_deploy/html/images/biomedicines-09-01484-g001.png)
Biomedicines | Free Full-Text | Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis | HTML
![study design. Abbreviations: cPR, c-reactive protein; RF, rheumatoid... | Download Scientific Diagram study design. Abbreviations: cPR, c-reactive protein; RF, rheumatoid... | Download Scientific Diagram](https://www.researchgate.net/publication/316549684/figure/fig2/AS:667791887720450@1536225401243/study-design-Abbreviations-cPR-c-reactive-protein-RF-rheumatoid-factor-esR_Q640.jpg)
study design. Abbreviations: cPR, c-reactive protein; RF, rheumatoid... | Download Scientific Diagram
![Cureus | Nivolumab-Induced Crescentic Immunoglobulin A Nephropathy With Henoch-Schonlein Purpura Features in a Patient Diagnosed With Hepatocellular Carcinoma Cureus | Nivolumab-Induced Crescentic Immunoglobulin A Nephropathy With Henoch-Schonlein Purpura Features in a Patient Diagnosed With Hepatocellular Carcinoma](https://assets.cureus.com/uploads/figure/file/273420/lightbox_eda189202e0a11ecae71cb59bfab018c-EM.png)
Cureus | Nivolumab-Induced Crescentic Immunoglobulin A Nephropathy With Henoch-Schonlein Purpura Features in a Patient Diagnosed With Hepatocellular Carcinoma
![Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand? | Immunology Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand? | Immunology](https://www.frontiersin.org/files/Articles/574271/fimmu-11-574271-HTML-r2/image_m/fimmu-11-574271-g001.jpg)
Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand? | Immunology
![PDF) Assessing immune organs on 18 F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients PDF) Assessing immune organs on 18 F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients](https://i1.rgstatic.net/publication/348408002_Assessing_immune_organs_on_18_F-FDG_PETCT_imaging_for_therapy_monitoring_of_immune_checkpoint_inhibitors_inter-observer_variability_prognostic_value_and_evolution_during_the_treatment_course_of_melano/links/5ffd6c7d299bf140888c9dd7/largepreview.png)
PDF) Assessing immune organs on 18 F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients
![Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review - ScienceDirect Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1558767320301634-gr2.jpg)
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review - ScienceDirect
![Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review - ScienceDirect Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1558767320301634-gr3.jpg)
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review - ScienceDirect
![PDF) Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis PDF) Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis](https://www.researchgate.net/publication/350840426/figure/tbl1/AS:1018329930153985@1619800183846/Characteristics-of-patients-with-rheumatic-immune-related-adverse-events-rh-irAEs_Q320.jpg)
PDF) Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis
![Pd-l1-binding Molecules Comprising Shiga Toxin A Subunit Scaffolds Poma; Eric ; et al. [Molecular Templates, Inc.] Pd-l1-binding Molecules Comprising Shiga Toxin A Subunit Scaffolds Poma; Eric ; et al. [Molecular Templates, Inc.]](https://uspto.report/patent/app/20210079098/US20210079098A1-20210318-D00000.png)
Pd-l1-binding Molecules Comprising Shiga Toxin A Subunit Scaffolds Poma; Eric ; et al. [Molecular Templates, Inc.]
![Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non–Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis - Clinical Lung Cancer Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non–Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/99d39486-ada1-4d17-8a8b-b69d689f8e6b/gr3_lrg.jpg)
Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non–Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis - Clinical Lung Cancer
![Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage? - European Journal of Cancer Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage? - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fa5242a4-f259-4a95-b901-f8609236b8de/gr4_lrg.jpg)